| 1 |
Marques LLM, Beneti SC, Pinzon C, Cardoso FAR. Ivermectin as a possible treatment for COVID-19: a review of the 2022 protocols. Braz J Biol 2024;84:e258325. [DOI: 10.1590/1519-6984.258325] [Reference Citation Analysis]
|
| 2 |
Takano K, de Hayr L, Carver S, Harvey RJ, Mounsey KE. Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife. Int J Parasitol Drugs Drug Resist 2023;21:97-113. [PMID: 36906936 DOI: 10.1016/j.ijpddr.2023.02.004] [Reference Citation Analysis]
|
| 3 |
Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Batiha GE. Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysauto-nomia. Curr Drug Targets 2022;23:1277-87. [PMID: 35950254 DOI: 10.2174/1389450123666220810102406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Gallagher CI, Ha DA, Harvey RJ, Vandenberg RJ. Positive Allosteric Modulators of Glycine Receptors and Their Potential Use in Pain Therapies. Pharmacol Rev 2022;74:933-61. [PMID: 36779343 DOI: 10.1124/pharmrev.122.000583] [Reference Citation Analysis]
|
| 5 |
Volkova YA, Rassokhina IV, Kondrakhin EA, Rossokhin AV, Kolbaev SN, Tihonova TB, Kh. Dzhafarov M, Schetinina MA, Chernoburova EI, Vasileva EV, Dmitrenok AS, Kovalev GI, Sharonova IN, Zavarzin IV. Synthesis and Evaluation of Avermectin–Imidazo[1,2-a]pyridine Hybrids as Potent GABAA Receptor Modulators. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105904] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 6 |
Zhang Y, Sun T, Li M, Lin Y, Liu Y, Tang S, Dai C. Ivermectin-Induced Apoptotic Cell Death in Human SH-SY5Y Cells Involves the Activation of Oxidative Stress and Mitochondrial Pathway and Akt/mTOR-Pathway-Mediated Autophagy. Antioxidants 2022;11:908. [DOI: 10.3390/antiox11050908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Huang CY, Nicholson MW, Wang JY, Ting CY, Tsai MH, Cheng YC, Liu CL, Chan DZH, Lee YC, Hsu CC, Hsu YH, Yang CF, Chang CMC, Ruan SC, Lin PJ, Lin JH, Chen LL, Hsieh ML, Cheng YY, Hsu WT, Lin YL, Chen CH, Hsu YH, Wu YT, Hacker TA, Wu JC, Kamp TJ, Hsieh PCH. Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons. Cell Rep 2022;39:110643. [PMID: 35385754 DOI: 10.1016/j.celrep.2022.110643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 8 |
Kaushik I, Srivastava SK. GABAA receptor agonist suppresses pediatric medulloblastoma progression by inhibiting PKA-Gli1 signaling axis. Mol Ther 2022:S1525-0016(22)00171-X. [PMID: 35331907 DOI: 10.1016/j.ymthe.2022.03.012] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 9 |
Savadelis MD, McTier TL, Kryda K, Maeder SJ, Woods DJ. Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance. Parasit Vectors 2022;15:82. [PMID: 35277180 DOI: 10.1186/s13071-021-05104-7] [Reference Citation Analysis]
|
| 10 |
Johnson-Arbor K. Ivermectin: a mini-review. Clin Toxicol (Phila) 2022;60:571-5. [PMID: 35225114 DOI: 10.1080/15563650.2022.2043338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Mounsey K, Harvey RJ, Wilkinson V, Takano K, Old J, Stannard H, Wicker L, Phalen D, Carver S. Drug dose and animal welfare: important considerations in the treatment of wildlife. Parasitol Res 2022. [PMID: 35147771 DOI: 10.1007/s00436-022-07460-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Rando HM, Wellhausen N, Ghosh S, Lee AJ, Dattoli AA, Hu F, Byrd JB, Rafizadeh DN, Lordan R, Qi Y, Sun Y, Brueffer C, Field JM, Ben Guebila M, Jadavji NM, Skelly AN, Ramsundar B, Wang J, Goel RR, Park Y, Boca SM, Gitter A, Greene CS; COVID-19 Review Consortium Vikas Bansal, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Das, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang, Nils Wellhausen. Identification and Development of Therapeutics for COVID-19. mSystems 2021;6:e0023321. [PMID: 34726496 DOI: 10.1128/mSystems.00233-21] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 13 |
Zarkesh K, Entezar-Almahdi E, Ghasemiyeh P, Akbarian M, Bahmani M, Roudaki S, Fazlinejad R, Mohammadi-Samani S, Firouzabadi N, Hosseini M, Farjadian F. Drug-based therapeutic strategies for COVID-19-infected patients and their challenges. Future Microbiol 2021;16:1415-51. [PMID: 34812049 DOI: 10.2217/fmb-2021-0116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Kaji MD, Noonan JD, Geary TG, Beech RN. Structural mechanism underlying the differential effects of ivermectin and moxidectin on the C. elegans glutamate-gated chloride channel GLC-2. Biomed Pharmacother 2022;145:112380. [PMID: 34749053 DOI: 10.1016/j.biopha.2021.112380] [Reference Citation Analysis]
|
| 15 |
Duarte D, Vale N. Combining repurposed drugs to treat colorectal cancer. Drug Discov Today 2021:S1359-6446(21)00406-2. [PMID: 34592446 DOI: 10.1016/j.drudis.2021.09.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Bousquet-Mélou A, Lespine A, Sutra JF, Bargues I, Toutain PL. A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients. Front Pharmacol 2021;12:666348. [PMID: 34093195 DOI: 10.3389/fphar.2021.666348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Muniz MS, Halbach K, Alves Araruna IC, Martins RX, Seiwert B, Lechtenfeld O, Reemtsma T, Farias D. Moxidectin toxicity to zebrafish embryos: Bioaccumulation and biomarker responses. Environ Pollut 2021;283:117096. [PMID: 33866217 DOI: 10.1016/j.envpol.2021.117096] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 18 |
Silva J, Carry E, Xue C, Zhang J, Liang J, Roberge JY, Davies DL. A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice. Molecules 2021;26:1791. [PMID: 33810134 DOI: 10.3390/molecules26061791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 19 |
Rendic SP. Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects. Arch Toxicol 2021;95:1535-46. [PMID: 33719007 DOI: 10.1007/s00204-021-03025-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 20 |
Branco SEMT, Mattoso CRS, Botelho AFM, Soto-Blanco B, Melo MM. Intravenous lipid emulsion treatment in rabbits with ivermectin toxicosis. J Vet Emerg Crit Care (San Antonio) 2021;31:340-50. [PMID: 33709617 DOI: 10.1111/vec.13048] [Reference Citation Analysis]
|
| 21 |
Martin RJ, Robertson AP, Choudhary S. Ivermectin: An Anthelmintic, an Insecticide, and Much More. Trends Parasitol 2021;37:48-64. [PMID: 33189582 DOI: 10.1016/j.pt.2020.10.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 22 |
El-Saber Batiha G, Alqahtani A, Ilesanmi OB, Saati AA, El-Mleeh A, Hetta HF, Magdy Beshbishy A. Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects. Pharmaceuticals (Basel) 2020;13:E196. [PMID: 32824399 DOI: 10.3390/ph13080196] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 23 |
Silva J, Khoja S, Asatryan L, Pacifici E, Davies DL. A novel pharmacotherapy approach using P-glycoprotein (PGP/ABCB1) efflux inhibitor combined with ivermectin to reduce alcohol drinking and preference in mice. Alcohol 2020;86:1-8. [PMID: 32278067 DOI: 10.1016/j.alcohol.2020.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 24 |
Chaccour C, Hammann F, Ramón-García S, Rabinovich NR. Ivermectin and COVID-19: Keeping Rigor in Times of Urgency. Am J Trop Med Hyg 2020;102:1156-7. [PMID: 32314704 DOI: 10.4269/ajtmh.20-0271] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 33.3] [Reference Citation Analysis]
|
| 25 |
Bernigaud C, Samarawickrama GR, Jones MK, Gasser RB, Fischer K. The Challenge of Developing a Single-Dose Treatment for Scabies. Trends Parasitol 2019;35:931-43. [PMID: 31474559 DOI: 10.1016/j.pt.2019.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 26 |
Prichard RK, Geary TG. Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance. Int J Parasitol Drugs Drug Resist 2019;10:69-83. [PMID: 31229910 DOI: 10.1016/j.ijpddr.2019.06.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 27 |
Ashour DS. Ivermectin: From theory to clinical application. Int J Antimicrob Agents 2019;54:134-42. [PMID: 31071469 DOI: 10.1016/j.ijantimicag.2019.05.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 28 |
Nowak-Sliwinska P, Scapozza L, Ruiz i Altaba A. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer. Biochim Biophys Acta Rev Cancer 2019;1871:434-54. [PMID: 31034926 DOI: 10.1016/j.bbcan.2019.04.005] [Cited by in Crossref: 90] [Cited by in F6Publishing: 71] [Article Influence: 22.5] [Reference Citation Analysis]
|
| 29 |
Makhani L, Khatib A, Corbeil A, Kariyawasam R, Raheel H, Clarke S, Challa P, Hagopian E, Chakrabarti S, Schwartz KL, Boggild AK. 2018 in review: five hot topics in tropical medicine. Trop Dis Travel Med Vaccines 2019;5:5. [PMID: 31016025 DOI: 10.1186/s40794-019-0082-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 30 |
Duthaler U, Suenderhauf C, Karlsson MO, Hussner J, Meyer Zu Schwabedissen H, Krähenbühl S, Hammann F. Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers. Br J Clin Pharmacol 2019;85:626-33. [PMID: 30566757 DOI: 10.1111/bcp.13840] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 31 |
Verdú JR, Cortez V, Martinez-Pinna J, Ortiz AJ, Lumaret JP, Lobo JM, Sánchez-Piñero F, Numa C. First assessment of the comparative toxicity of ivermectin and moxidectin in adult dung beetles: Sub-lethal symptoms and pre-lethal consequences. Sci Rep 2018;8:14885. [PMID: 30291291 DOI: 10.1038/s41598-018-33241-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 32 |
Margier M, Collet X, le May C, Desmarchelier C, André F, Lebrun C, Defoort C, Bluteau A, Borel P, Lespine A, Reboul E. ABCB1 (P-glycoprotein) regulates vitamin D absorption and contributes to its transintestinal efflux. FASEB J 2019;33:2084-94. [PMID: 30222077 DOI: 10.1096/fj.201800956R] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 33 |
Nashat MA, Ricart Arbona RJ, Lepherd ML, Santagostino SF, Livingston RS, Riedel ER, Lipman NS. Ivermectin-compounded Feed Compared with Topical Moxidectin-Imidacloprid for Eradication of Demodex musculi in Laboratory Mice. J Am Assoc Lab Anim Sci 2018;57:483-97. [PMID: 30185284 DOI: 10.30802/AALAS-JAALAS-18-000003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 34 |
Hosseini Omshi FS, Abbasalipourkabir R, Abbasalipourkabir M, Nabyan S, Bashiri A, Ghafourikhosroshahi A. Effect of vitamin A and vitamin C on attenuation of ivermectin-induced toxicity in male Wistar rats. Environ Sci Pollut Res 2018;25:29408-17. [DOI: 10.1007/s11356-018-2961-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 35 |
Khoja S, Huynh N, Warnecke AMP, Asatryan L, Jakowec MW, Davies DL. Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders. Psychopharmacology (Berl) 2018;235:1697-709. [PMID: 29500584 DOI: 10.1007/s00213-018-4869-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 36 |
Spampanato J, Gibson A, Dudek FE. The antihelminthic moxidectin enhances tonic GABA currents in rodent hippocampal pyramidal neurons. J Neurophysiol 2018;119:1693-8. [PMID: 29364072 DOI: 10.1152/jn.00587.2017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 37 |
Chaccour C, Hammann F, Rabinovich NR. Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar J 2017;16:161. [PMID: 28434401 DOI: 10.1186/s12936-017-1801-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 38 |
Degani-Katzav N, Gortler R, Weissman M, Paas Y. Mutational Analysis at Intersubunit Interfaces of an Anionic Glutamate Receptor Reveals a Key Interaction Important for Channel Gating by Ivermectin. Front Mol Neurosci 2017;10:92. [PMID: 28428744 DOI: 10.3389/fnmol.2017.00092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 39 |
Degani-Katzav N, Klein M, Har-Even M, Gortler R, Tobi R, Paas Y. Trapping of ivermectin by a pentameric ligand-gated ion channel upon open-to-closed isomerization. Sci Rep 2017;7:42481. [PMID: 28218274 DOI: 10.1038/srep42481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 40 |
Bernigaud C, Fang F, Fischer K, Lespine A, Aho LS, Dreau D, Kelly A, Sutra JF, Moreau F, Lilin T, Botterel F, Guillot J, Chosidow O. Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model. PLoS Negl Trop Dis 2016;10:e0005030. [PMID: 27732588 DOI: 10.1371/journal.pntd.0005030] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 41 |
Raza A, Bagnall NH, Jabbar A, Kopp SR, Kotze AC. Increased expression of ATP binding cassette transporter genes following exposure of Haemonchus contortus larvae to a high concentration of monepantel in vitro. Parasit Vectors 2016;9:522. [PMID: 27682865 DOI: 10.1186/s13071-016-1806-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 42 |
Huynh N, Arabian N, Naito A, Louie S, Jakowec MW, Asatryan L, Davies DL. Preclinical development of moxidectin as a novel therapeutic for alcohol use disorder. Neuropharmacology 2017;113:60-70. [PMID: 27641072 DOI: 10.1016/j.neuropharm.2016.09.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 43 |
Ménez C, Alberich M, Kansoh D, Blanchard A, Lespine A. Acquired Tolerance to Ivermectin and Moxidectin after Drug Selection Pressure in the Nematode Caenorhabditis elegans. Antimicrob Agents Chemother 2016;60:4809-19. [PMID: 27246778 DOI: 10.1128/AAC.00713-16] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 44 |
Heusser SA, Yoluk Ö, Klement G, Riederer EA, Lindahl E, Howard RJ. Functional characterization of neurotransmitter activation and modulation in a nematode model ligand-gated ion channel. J Neurochem 2016;138:243-53. [PMID: 27102368 DOI: 10.1111/jnc.13644] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 45 |
Raza A, Kopp SR, Bagnall NH, Jabbar A, Kotze AC. Effects of in vitro exposure to ivermectin and levamisole on the expression patterns of ABC transporters in Haemonchus contortus larvae. Int J Parasitol Drugs Drug Resist 2016;6:103-15. [PMID: 27164439 DOI: 10.1016/j.ijpddr.2016.03.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 46 |
Raza A, Kopp SR, Jabbar A, Kotze AC. Effects of third generation P-glycoprotein inhibitors on the sensitivity of drug-resistant and -susceptible isolates of Haemonchus contortus to anthelmintics in vitro. Veterinary Parasitology 2015;211:80-8. [DOI: 10.1016/j.vetpar.2015.04.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 47 |
Greenberg RM. Ion channels and drug transporters as targets for anthelmintics. Curr Clin Microbiol Rep 2014;1:51-60. [PMID: 25554739 DOI: 10.1007/s40588-014-0007-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 48 |
Kotze AC, Hunt PW, Skuce P, von Samson-Himmelstjerna G, Martin RJ, Sager H, Krücken J, Hodgkinson J, Lespine A, Jex AR, Gilleard JS, Beech RN, Wolstenholme AJ, Demeler J, Robertson AP, Charvet CL, Neveu C, Kaminsky R, Rufener L, Alberich M, Menez C, Prichard RK. Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor interactions. Int J Parasitol Drugs Drug Resist 2014;4:164-84. [PMID: 25516826 DOI: 10.1016/j.ijpddr.2014.07.007] [Cited by in Crossref: 115] [Cited by in F6Publishing: 123] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 49 |
Bygarski EE, Prichard RK, Ardelli BF. Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes. Int J Parasitol Drugs Drug Resist 2014;4:143-51. [PMID: 25516824 DOI: 10.1016/j.ijpddr.2014.06.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 50 |
Asatryan L, Yardley MM, Khoja S, Trudell JR, Hyunh N, Louie SG, Petasis NA, Alkana RL, Davies DL. Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders. Int J Neuropsychopharmacol 2014;17:907-16. [PMID: 24451653 DOI: 10.1017/S1461145713001703] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 51 |
Hernando G, Bouzat C. Caenorhabditis elegans neuromuscular junction: GABA receptors and ivermectin action. PLoS One 2014;9:e95072. [PMID: 24743647 DOI: 10.1371/journal.pone.0095072] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 52 |
Lespine A. Lipid-like properties and pharmacology of the anthelmintic macrocyclic lactones. Expert Opinion on Drug Metabolism & Toxicology 2013;9:1581-95. [DOI: 10.1517/17425255.2013.832200] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 53 |
Ozoe Y. γ-Aminobutyrate- and Glutamate-gated Chloride Channels as Targets of Insecticides. Advances in Insect Physiology 2013. [DOI: 10.1016/b978-0-12-394389-7.00004-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 7.3] [Reference Citation Analysis]
|
